Earningsreport

Q2/2023 3/31/2023 EPS -0.070 ZacksConsensus -0.040 ActVsEst (0.030) - Miss

Citius Pharmaceuticals, Inc.  (CTXR) 
NASDAQ:AMEX Investor Relations: ir.citiuspharma.com